Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common stock	Additional paid-in capital	Additional paid-in capital Cumulative Effect, Period of Adoption, Adjustment	Accumulated other comprehensive income (loss)	Accumulated deficit	Accumulated deficit Cumulative Effect, Period of Adoption, Adjustment
Balance (in shares) at Dec. 31, 2019			91,749,933
Balance at Dec. 31, 2019	$ 93,532		$ 92	$ 310,621		$ (449)	$ (216,732)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	68,585			68,585
Common stock issued under employee stock plans, net (shares)			3,600,003
Common stock issued under employee stock plans, net	10,293		$ 3	10,290
Taxes paid related to net share settlement of equity awards	(502)			(502)
Issuance of common stock from acquisitions (in shares)			106,926
Issuance of common stock from acquisitions	4,198		$ 0	4,198
Fair value of replacement equity awards attributable to pre-acquisition service	709			709
Realized and unrealized gains (losses) on derivative	9,838					9,838
Unrealized income (loss) in available for sale securities	(18)					(18)
Purchase of capped calls related to Convertible senior notes	(29,348)			(29,348)
Equity component of Convertible senior notes, net	30,794			30,794
Net loss	(94,010)						(94,010)
Balance (in shares) at Dec. 31, 2020			95,456,862
Balance at Dec. 31, 2020	94,071		$ 95	395,347		9,371	(310,742)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Common stock in connection with follow-on offering, net of issuance costs of $17,466 (in shares)			7,961,538
Issuance of Common stock in connection with follow-on offering, net of issuance costs of $17,466	500,034		$ 8	500,026
Stock-based compensation expense	109,779			109,779
Common stock issued under employee stock plans, net (shares)			4,090,696
Common stock issued under employee stock plans, net	13,902		$ 5	13,897
Taxes paid related to net share settlement of equity awards	(1,044)			(1,044)
Realized and unrealized gains (losses) on derivative	(3,285)					(3,285)
Unrealized income (loss) in available for sale securities	(3)					(3)
Net loss	(116,861)						(116,861)
Balance (in shares) at Dec. 31, 2021			107,509,096
Balance at Dec. 31, 2021	$ 596,593	$ (22,147)	$ 108	1,018,005	$ (30,794)	6,083	(427,603)	$ 8,647
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible List]	Accounting Standards Update 2020-06 [Member]
Stock-based compensation expense	$ 142,862			142,862
Common stock issued under employee stock plans, net (shares)			3,078,402
Common stock issued under employee stock plans, net	12,496		$ 3	12,493
Taxes paid related to net share settlement of equity awards	$ (31,076)			(31,076)
Repurchase of common stock (in shares)	(2,914,446)		(2,914,446)
Repurchase of common stock	$ (56,445)		$ (3)	(56,442)
Realized and unrealized gains (losses) on derivative	(15,363)					(15,363)
Unrealized income (loss) in available for sale securities	(277)					(277)
Net loss	(124,518)						(124,518)
Balance (in shares) at Dec. 31, 2022			107,673,052
Balance at Dec. 31, 2022	$ 502,125		$ 108	$ 1,055,048		$ (9,557)	$ (543,474)